Pantoprazole combined with famotidine treatment of duodenal ulcer.docVIP

Pantoprazole combined with famotidine treatment of duodenal ulcer.doc

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Pantoprazole combined with famotidine treatment of duodenal ulcer

 PAGE \* MERGEFORMAT 11 Pantoprazole combined with famotidine treatment of duodenal ulcer [Abstract] Objective To observe the oral administration of pantoprazole combined with famotidine treatment of active duodenal ulcer (DU clinical efficacy. Methods of Helicobacter pylori (HP-negative activity of the 59 patients with duodenal ulcer were randomly divided into two groups, which together with the group of 32 patients given pantoprazole combined with famotidine treatment group of 27 patients were given single drug pantoprazole treatment. a course of 4 weeks. The results of treatment, the pain lost time, the combination group was 2.4 + -2.2 days, the single drug group and 3.7 + -2.5 days, two groups had significant difference (P lt;0.05. in the ulcer healing rate, the combination group was 90.6%, single healing rate of 81.5% drug group showed no significant difference (Pgt; 0. 05. Conclusion of oral pantoprazole therapy combined with famotidine DU, relieve symptoms quickly and effectively, to a certain extent, improve the rate of ulcer healing , and worth further clinical application. [Keywords:] pantoprazole peptic ulcer famotidine Duodenal ulcer (duodenal uncler, DU is the digestive system of the common disease, accounting for about 80% of the peptic ulcer. Research has made it clear, DU occurrence with a variety of factors, including gastric acid, gastric Helicobacter pylori protease and factors such as increased attack, and the gastric mucosal barrier, mucosal blood flow, prostaglandins, bicarbonate secretion and epithelial regeneration of the weakened defense factor. Although the initiating factors may vary, but in the formation of ulcers process, the acid digestion itself always occupy a decisive factor, therefore, inhibition of gastric acid into DU treatment of one of the most important measures [1]. current proton pump inhibitor (PPI or H2 receptor antagonist (H2RA and other acid-suppressing DU treatment agent is the most commonly used convention

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档